Sevbela
Sevbela contains Sevelamer Carbonate, a non-calcium, non-metal phosphate binder. It binds to dietary phosphorus in the gastrointestinal tract, preventing its absorption and thereby lowering phosphate levels in the blood of patients undergoing dialysis.
Dosage by Body Weight
Must be taken with meals. The dosage is highly individualized and must be adjusted by a physician based on the patient's serum phosphorus levels. Tablets must be swallowed whole; do not crush, chew, or break.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and efficacy have not been established in patients in this weight range.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and efficacy have not been established in patients in this weight range.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and efficacy have not been established in pediatric patients under this weight range.
- Body Weight
- 11-15 kg
- Dose
- Not routinely prescribed
- Frequency
- Consult pediatric nephrologist
- Tracking Notes
- Pediatric dosing is typically based on Body Surface Area (BSA) rather than weight alone. Use only under strict specialist supervision.
- Body Weight
- 16-20 kg
- Dose
- Not routinely prescribed
- Frequency
- Consult pediatric nephrologist
- Tracking Notes
- Pediatric dosing is based on Body Surface Area (BSA) and serum phosphorus targets. Consult a specialist for precise dosing.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | Do not use | Safety and efficacy have not been established in patients in this weight range. |
| 5-7 kg | Not recommended | Do not use | Safety and efficacy have not been established in patients in this weight range. |
| 8-10 kg | Not recommended | Do not use | Safety and efficacy have not been established in pediatric patients under this weight range. |
| 11-15 kg | Not routinely prescribed | Consult pediatric nephrologist | Pediatric dosing is typically based on Body Surface Area (BSA) rather than weight alone. Use only under strict specialist supervision. |
| 16-20 kg | Not routinely prescribed | Consult pediatric nephrologist | Pediatric dosing is based on Body Surface Area (BSA) and serum phosphorus targets. Consult a specialist for precise dosing. |
Formulation
TabletPowder for Oral Suspension
Purpose
Used to control serum phosphorus levels (phosphate binder) in patients with chronic kidney disease (CKD) on dialysis.
Generic Name
Sevelamer CarbonateScheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.